Fragile X syndrome (FXS) is a multi-organ disease that leads to mental retardation, macro-orchidism in males and premature ovarian insufficiency in female carriers. FXS is also a prominent monogenic disease associated with autism spectrum disorders (ASDs). FXS is typically caused by the loss of fragile X mental retardation 1 (FMR1) expression, which codes for the RNA-binding protein FMRP. Here we report the discovery of distinct RNA-recognition elements that correspond to the two independent RNA-binding domains of FMRP, in addition to the binding sites within the messenger RNA targets for wild-type and I304N mutant FMRP isoforms and the FMRP paralogues FXR1P and FXR2P (also known as FXR1 and FXR2). RNA-recognition-element frequency, ratio and distribution determine target mRNA association with FMRP. Among highly enriched targets, we identify many genes involved in ASD and show that FMRP affects their protein levels in human cell culture, mouse ovaries and human brain. Notably, we discovered that these targets are also dysregulated in Fmr1 2/2 mouse ovaries showing signs of premature follicular overdevelopment. These results indicate that FMRP targets share signalling pathways across different cellular contexts. As the importance of signalling pathways in both FXS and ASD is becoming increasingly apparent, our results provide a ranked list of genes as basis for the pursuit of new therapeutic targets for these neurological disorders.
Fragile X syndrome (FXS) is a multi-organ disease that leads to mental retardation, macro-orchidism in males and premature ovarian insufficiency in female carriers. FXS is also a prominent monogenic disease associated with autism spectrum disorders (ASDs). FXS is typically caused by the loss of fragile X mental retardation 1 (FMR1) expression, which codes for the RNA-binding protein FMRP. Here we report the discovery of distinct RNA-recognition elements that correspond to the two independent RNA-binding domains of FMRP, in addition to the binding sites within the messenger RNA targets for wild-type and I304N mutant FMRP isoforms and the FMRP paralogues FXR1P and FXR2P (also known as FXR1 and FXR2). RNA-recognition-element frequency, ratio and distribution determine target mRNA association with FMRP. Among highly enriched targets, we identify many genes involved in ASD and show that FMRP affects their protein levels in human cell culture, mouse ovaries and human brain. Notably, we discovered that these targets are also dysregulated in Fmr1 2/2 mouse ovaries showing signs of premature follicular overdevelopment. These results indicate that FMRP targets share signalling pathways across different cellular contexts. As the importance of signalling pathways in both FXS and ASD is becoming increasingly apparent, our results provide a ranked list of genes as basis for the pursuit of new therapeutic targets for these neurological disorders.
Most clinical cases of FXS are a result of a hyper-expansion and methylation of CGG repeats within the promoter of FMR1, leading to a loss of its expression [1] [2] [3] . The FMR1 RNA-binding protein family has three members, FMRP, FXR1P and FXR2P, which possess two centrally located KH domains and a carboxy-terminal arginineglycine-rich region implicated in mRNA binding [4] [5] [6] [7] . FMR1 codes for multiple protein isoforms, but is predominantly expressed as a 69 kDa protein (isoform 7) 8, 9 . Isoform 1 and six other alternative splice variants include exon 12, with isoform 1 coding for the fulllength protein (71 kDa). Exon 12 insertion lengthens the second KH (KH2) RNA-binding domain, possibly influencing FMRP RNAbinding specificity or affinity. The I304N mutation, first described in a FXS patient, is also located in the KH2 domain and is reported to attenuate association with RNA and polysomes [10] [11] [12] . FMR1-family proteins are implicated in various RNA processes including RNA subcellular localization by facilitating nucleo-cytoplasmic shuttling 13 and association with motor proteins [14] [15] [16] , and are also suggested to mediate translational regulation 12, 17 . Given the critical role of FMR1 in human cognition and premature ovarian insufficiency 18, 19 , there have been intensive efforts towards the identification of the RNA targets of FMRP, with the view that their discovery would shed light on the array of related disorders and provide options for molecular therapy [18] [19] [20] [21] [22] [23] [24] [25] [26] . No precise RNA-recognition element (RRE) has been defined and very few bona fide mRNA targets are confirmed 27 .
RNA target sites of the FMR1 protein family
To identify the binding sites of FMR1-family proteins ( Fig. 1a and Supplementary Fig. 1 ), we first compared photocrosslinking methods [28] [29] [30] using stable Flag-haemagglutinin (HA)-tagged FMRP isoform 7 in HEK293 cells ( Fig. 1b ), as these cells and human brain share 90% of expressed genes according to a comparison of existing RNA-seq data sets [31] [32] [33] ( Supplementary Fig. 2) . The difference between FMR1 levels in the experimental system and the brain is 1.3-fold, as calculated using RNA-seq data and the quantified expression of FMR1 in our stable cells. We found that 4-thiouridine (4SU) photoactivatable ribonucleosideenhanced crosslinking and immunoprecipitation (PAR-CLIP) provided the highest yield of crosslinked RNAs, and this approach was used for all FMR1-family proteins ( Fig. 1c ). Complementary DNA libraries were generated after PAR-CLIP and Illumina-sequenced (Supplementary Table 1 ). Genome-aligned reads were grouped by PARalyzer 34 to identify segments of RNA that represented peaks of T-to-C conversion, termed binding sites. PARalyzer separated closely spaced binding sites connected by overlapping reads and yielded a median RNA segment length of 33 nucleotides ( Supplementary Fig. 3 ). FMRP isoforms 1 and 7 bound to approximately 80,000-100,000 sites, of which .85% mapped to ,6,000 mRNAs (Supplementary Tables 1, 2 and http://fmrp.rockefeller.edu). FXR1P and FXR2P protein binding sites are comprised within FMRP binding sites, with an overlap of 95% (Supplementary Table 3 ).
Nearly all mRNA-binding sites were located in exons (.90%) ( Fig. 2a ) and distributed between coding sequence (CDS) and 39 untranslated regions (UTRs) (.95%, total), with slightly more CDS sites, similar to distributions seen for other cytoplasmic RNA-binding proteins 28 . The computational sequence analysis method cERMIT 35 revealed two key RREs, ACUK and WGGA (in which K 5 G or U and W 5 A or U) ( Fig. 2b and Supplementary Fig. 4 ). Together, ACUK and WGGA RREs were found in $50% of mRNA-binding sites in isoforms 1 and 7, occurring exclusively or together within the same binding site ( Fig. 2c ). Remaining binding sites typically contained close derivatives of either RRE.
Characterization of the RREs of FMRP
We performed electrophoretic mobility shift assays (EMSAs) to test RNAs representing FMRP binding sites using recombinant human FMRP purified from Spodoptera frugiperda 9 (Sf9) cells (Supplementary Figs 5 and 6). FMRP target sites were selected on the basis of whether they contained ACUK, WGGA or mixed (ACUK and WGGA) RREs (Supplementary Table 4 ). Testing RNAs of various lengths, we found that oligonucleotide lengths of $45 nucleotides were required to observe gel shifts and reach dissociation constants below 0.5 mM, suggesting that RNA backbone contacts outside of the RREs contribute to the association in vitro. WGGA-containing RNAs exhibited the widest range and strongest affinities, generally correlating with the number of RREs within a PARalyzer-defined binding site. An RNA segment containing nine WGGAs bound almost two orders of magnitude tighter than those containing one WGGA, whereas binding of ACUK-containing RNAs varied only fivefold. EMSAs using RNAs representing target sites within PPP2CA and UBE3A are shown in Fig. 3a .
We also tested sites in APP and FMR1 mRNA ( Supplementary  Fig. 7 ), two previously identified mRNA targets. APP was originally discovered as an FMRP target on the basis of a predicted G-quartet region 7 although the actual site was subsequently identified in vitro at an upstream segment 36 , which was identified here (APP site 1) as containing WGGA. FMRP targets its own mRNA, although this association was only observed in vitro 5, 6, 37 and in immunoprecipitates 38 .
Recombinant I304N isoform 1 FMRP showed an ,tenfold average decrease in its affinity towards ACUK-containing RNAs compared to wild-type FMRP isoform 1 ( Fig. 3b and Supplementary Table 5 ). We characterized binding to wild-type and mutant RNA sequences derived from an NF1 mixed RRE site ( Fig. 3c ). I304N FMRP bound wild-type and NF1 ACUK(2) RNAs similarly, whereas wild-type FMRP showed a twofold reduction in affinity for NF1 ACUK (2) RNA. In addition, wild-type FMRP binding curves for NF1 ACUK, WGGA(2) RNA were similar to I304N FMRP binding curves for NF1 WGGA(2) RNA. Our results indicate that the KH2 domain associates with the ACUK RRE. As FMRP associates with mRNAs at more than one binding site, its association at multiple sites will affect the final regulatory effect. We compared the distribution of RREs in I304N FMRP versus wild-type FMRP PAR-CLIPs and found a transcriptome-wide depletion in the recovery of sequence reads for ACUK binding sites for both I304N isoforms, consistent with the biochemistry (Fig. 3d ). Interestingly, the RRE fractional distribution of I304N FMRP isoform 1 was similar to wild-type FMRP isoform 7, suggesting that alteration of the KH2 domain by mutation or exon insertion affects binding-site selectivity. Taken together, the biochemical and PAR-CLIP results with I304N FMRP indicate that we identified the natural target sites of the FMRP KH2 domain.
Ranked enrichment of the mRNA targets of FMRP
To rank FMRP targets, we measured their enrichment by ribonucleoprotein immunoprecipitation followed by microarray analysis (RIP-chip), which would indicate stable interactions. In total, 3,593 PAR-CLIP-identified targets showed enrichment by RIP-chip, of which 939 genes were two-to sixfold enriched; 646 transcripts were twofold enriched but not identified as PAR-CLIP targets. We used binding-site information obtained by PAR-CLIP to infer the salient features for stable association in RIP-chip ( Fig. 4 , Supplementary Fig. 8 and Supplementary Table 6 ). Increasing frequency of WGGA-and ACUK-containing elements led to greater RIP-chip enrichment, in agreement with in vitro affinity measurements. On average, top targets contained more RRE binding sites ( 
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identified 93 genes independently implicated in ASD among the highly enriched FMRP targets ( Fig. 4d and Supplementary Table 7) , which is notable given the relationship between FXS and ASD 20, 21, 39 . Enrichment of RNAs in RIP-chip depends on the saturation of target sites with FMRP. To estimate the yield of saturation, protein copy number, target mRNA copies and the number of binding sites within those transcripts have to be accounted. We determined endogenous and co-expressed Flag-HA-tagged FMR1 protein copy numbers to be approximately 60,000 and 70,000 molecules per cell, respectively, using quantitative western blotting and reference recombinant protein. Each cell contains 20 pg total RNA, 4% of which is mRNA and representing approximately 1 million molecules. Considering their relative abundance on the basis of HEK293 RNA-seq, we estimate that an equal distribution of FMRP would occupy 6% of binding sites per cell among its 6,000 target transcripts, or up to 20% if FXR1P and FXR2P protein estimates are included. Because PAR-CLIP-identified targets had varying enrichment, their association with FMRP is not uniform. The ,3,500 transcripts enriched in RIP-chip are estimated to have at least 18% FMRP binding-site occupancy, whereas the 900 top-ranked genes (twofold enriched) potentially exhibit 78%. The presence of multiple binding sites within targets suggests that multiple FMR1-family proteins bind each transcript to influence their regulation.
Regulatory impact of FMRP on its mRNA targets
To assess the effect of FMRP binding sites on mRNA stability, small interfering (siRNA) knockdown of FMR1 or the FMR1 family was performed and mRNA-expression profiles were analysed by microarray. We found no evidence for FMRP affecting target mRNA abundance (data not shown).
A panel of FMRP targets was selected on the basis of enrichment in RIP-chip, low-to-intermediate expression in RNA-seq, similar abundance in the human brain (using published microarray 31 and RNA-seq data sets 32, 33 ) and with documented neurological and human disease relevance, and then analysed by quantitative western blot to determine protein levels as a function of FMRP expression ( Fig. 4e ). FXR2P, HUWE1, KDM5C and MTOR protein levels, among others, showed up to 30% reduction in protein levels upon expression of FMRP in HEK293. We analysed lysates prepared from human post-mortem brains. Four FXS brains ( Supplementary Fig. 9 ) were available with age/sex/anatomic-matched controls from prefrontal cortical, hippocampal and cerebellar regions. Although only four out of eight antibodies yielded quantifiable bands in brain lysates, we observed a general trend of elevated target protein expression levels in FXS brains. This is the inverse of FMRP-overexpression effects in HEK293, and consistent with FMRP affecting the protein levels of its mRNA targets.
The mRNA targets identified here are from a human transcriptome in which most genes are comparably expressed in the human brain ( Supplementary Fig. 2 ). We discovered ASD-related and numerous other genes implicated in neuronal disorders associated with FXS and validated representatives by EMSA, RIP-chip and immunoblot. We found genes involved in Angelman, Prader-Willi, Rett, and Cornelia de Lange syndromes. Interestingly, the ASD and Angelman syndrome-associated gene UBE3A ubiquitinates ARC and SACS 40 ; ARC is a well-known target and here we identify SACS as a targeted transcript. These findings potentially provide the molecular link to tie together elements of clinically overlapping disorders, principally setting a molecular target framework for characterizing the connections between FXS and its associated phenotypes.
Although fragile-X-related diseases are primarily considered to be CNS disorders, at least two other target organs are affected: the testes and ovaries. We reasoned that changes in FMR1 expression lead to dysregulation of largely overlapping sets of targets shared across all affected organs. Thus, dysregulated genes and pathways in the brain might also contribute to phenotypes in the testes and ovaries. We therefore examined the ovaries of Fmr1 2/2 mice 41 as CNS and macroorchidism phenotypes had been reported, yet ovary development had largely been under-investigated. Ovaries from Fmr1 2/2 mice were markedly larger by 3 weeks post-birth compared to wild-type controls (Fig. 5a, b) . At 12 and 18 weeks post-birth, knockout ovaries were 22% and 72% larger by mass compared to age-matched controls, respectively. Notably, we found increased protein levels of Tsc2, Sash1 and Mtor (Fig. 5c ). As a role for the Mtor pathway in the regulation of ovarian development has been previously identified, it is tempting to 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 1,000 Figure 3 | RNA-binding assays using natural FMRP target sites containing ACUK and WGGA RREs, and the effect of a KH2 mutation to its target RNA spectrum. a, Top left, EMSAs of RNAs representing UBE3A or PPP2CA binding sites containing various RREs. Top right, binding curves and dissociation constants (K d ) are shown. Bottom, the sequences of the RNAs are provided, with WGGA (yellow) and ACUK RREs (cyan) highlighted. b, Effect of the KH2 mutation in FMRP on target sites containing ACUK versus WGGA RREs. The RNA affinities of wild-type and I304N FMRP isoform 1 were compared using binding sites in NF1 (ACUK) and FMR1 (WGGA). c, Binding curves of wild-type and I304N FMRP for an RNA segment representing a mixed RRE binding site in NF1, and several mutant sequence versions (ACUK(2), WGGA(2) and ACUK, WGGA(2)). d, Comparison of FMRP isoform 1 affinity for RRE type in EMSAs and FMRP isoforms 1 and 7 wild-type and I304N PAR-CLIP libraries. Error bars in EMSA summary (left) represent s.d., n 5 9 (ACUK) or 8 (WGGA). The ratio of sequence reads aligned to each RRE binding site was calculated between wild-type and I304N FMRP PAR-CLIP libraries. The average sequence-depth ratio of wild-type over I304N binding site, per RRE type, are shown. Error bars in the read-depth analyses (middle and right) represent the average minimum and maximum values across all subsampled mutant libraries (n 5 14 and 26 for isoforms 1 and 7, respectively).
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conclude that increased activity, in the absence of Fmr1 expression, contributes to enlarged ovaries histologically consistent with precocious follicular development. These observations suggest that Fmr1 knockout mice have the potential to model FXS-related premature ovarian insufficiency, in which it remains unclear whether elevated FMR1 mRNA or the observed reduction of FMRP protein itself is causative in female carriers affected by this disease.
Increased signal-transduction activity of the Mtor pathway 42, 43 was reported in Fmr1 knockout mice, and was attributed to Fmrp targeting of Pik3ca mRNA. Indeed, PAR-CLIP identified several FMRP binding sites within the human PIK3CA transcript. However, we find that it is a less-enriched RIP-chip target compared to MTOR and TSC2, whose protein levels appear regulated in an FMRP-dependent manner. Interestingly, recent evidence demonstrated that Tsc mutant mice [44] [45] [46] , which have increased Mtor activity, had impaired mGluRinduced long-term synaptic depression and protein synthesis compared to Fmr1 2/2 mice; crossing Tsc2 1/2 with Fmr1 2/y mice corrected the phenotypes 44 . Given our results it is likely that the decreased protein synthesis observed in Tsc2 1/2 mice is due to the Mtor pathway inducing increased FMRP regulatory activity, a consequence which can be alleviated through the removal of FMRP itself in Tsc2 1/2 Fmr1 2/y mice. However, it should be noted that FMRP can also associate with transcripts of ERK pathway components. Therapeutic targeting of the MTOR pathway has become an important goal, but must be further guided by additional functional analysis, particularly of FMRP targets upstream and downstream of MTOR and interconnected signalling pathways ( Supplementary Fig. 10 ). Combined, our validation work in Fmr1 knockout mouse ovaries and in human brain demonstrate that the effect of FMRP binding to specific target genes identified in cell culture is extensible to physiologically relevant contexts. and Fmr1 2/2 female mice were collected at 3, 9, 12 and 18 weeks and processed for histological (a), morphological (b) and quantitative western analyses (c). By 3 weeks of age, histological staining (haematoxylin) of sectioned ovaries showed a greater than expected number of follicles compared to wild type (a). Ovaries from 18-week-old Fmr1 2/2 mice are larger than those from wild type and exhibit prominent cysts consistent with corpus luteal development (b). Lysates were prepared from 9-, 12-and 18-week-old ovaries from two different wildtype and knockout mice each, and analysed by quantitative western blot using Mtor, Sash1 and Tsc2 antibodies. As for human samples, Pabpc1 was used for normalization (c). PAR-CLIP analyses in HEK293 cells and human brain. In cell culture, targetprotein expression differences of indicated proteins were determined upon induction of FMRP isoform 1 or 7 expression. Similarly, relative protein expression was measured using lysates prepared from indicated brain regions of four FXS patients, compared to age/sex/anatomic-matched controls. Error bars denote s.e.m.; n 5 2-11 (depending on protein measured and whether the sample was HEK293 or brain lysate). PABPC1 protein level served as a loading and ratio control as it was a gene with PAR-CLIP binding sites but showed no RIP-chip enrichment (20.10 log 2 -fold enrichment). *P , 0.05.
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METHODS SUMMARY
Methods are described in greater detail in Supplementary Information. FVB129P2 fragile X mice were a gift from S. Zukin. Gateway plasmids (Invitrogen) generated in this study will be deposited in http://www.addgene.org. FlpIn TRex HEK293 (Invitrogen) inducible stable cell lines were generated per manufacturer's instructions. The titres, source and use of antibodies used in this study are listed in Supplementary Information. PAR-CLIP was performed essentially as described, except that the second RNase T1 digestion was omitted following the immunoprecipitation. Recombinant wild-type and mutant FMRP isoform 1 proteins were purified using a baculovirus expression system (Invitrogen). EMSAs and western blots were quantified using ImageGauge (Fuji). Parameters of computation analyses are described in Supplementary Information and in the relevant sections at http://fmrp.rockefeller.edu/. Relevant data sets, including raw data, are available at http://fmrp.rockefeller.edu/ and gene expression omnibus (GSE39686).
